Even if berberine does increase endogenous GLP-1 levels to some degree, this indirect effect is mechanistically and clinically distinct from the direct receptor agonism provided by pharmaceutical GLP-1 agonists
GLP-1s are unlikely to deliver therapeutic value when so many individuals stop treatment after two years, but the findings also illustrate the need for obesity care management programs to improve adherence. Prime/MRx has been at the forefront of GLP-1 insights since we released our year-one research, and though we continue to see declines in persistence and adherence, we are committed to providing clients with actionable data and insights that can steer positive health outcomes for individuals. David Lassen, chief clinical officer David Lassen, chief clinical officer While real-world data is central to discussions about affordability and access, especially as the popularity of GLP-1 drugs for weight loss continues to climb, so too are comprehensive management strategies
For advanced type 2 diabetes with significant beta cell failure, or for type 1 diabetes, Tresiba (or another insulin) is essential and often superior to or required in addition to GLP-1 therapy
At week 52, participants that were treated with tirzepatide were not a higher risk of cardiovascular risk than those who were treated with insulin Glargine, metformin, and other glucose-lowering medications